Chase Science Co., Ltd (SHE:300941)
China · Delayed Price · Currency is CNY 23.52
+0.04 (0.17%)
At close: Feb 6, 2026
Chase Science Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 42.63 | 55.61 | 81.27 | 110.52 | 106.03 | 146.37 |
Depreciation & Amortization | 4.72 | 4.72 | 5.21 | 5.3 | 4.03 | 0.82 |
Other Amortization | 0.84 | 0.84 | 0.97 | 0.99 | 0.81 | 0.58 |
Loss (Gain) From Sale of Assets | 0.06 | 0.06 | -0 | - | - | 0.02 |
Asset Writedown & Restructuring Costs | -7.65 | -7.65 | -2.19 | 0 | 0 | - |
Loss (Gain) From Sale of Investments | -34.91 | -34.91 | -35.62 | -32.53 | -24.61 | -6.38 |
Provision & Write-off of Bad Debts | -2.26 | -2.26 | -4.58 | 6.76 | 10.02 | 6.55 |
Other Operating Activities | -101.07 | 1.73 | 1.03 | 0.45 | 0.44 | -0.13 |
Change in Accounts Receivable | 26.11 | 26.11 | -29.95 | -11.67 | -1.69 | 13.14 |
Change in Inventory | -18.87 | -18.87 | 8.87 | -5.62 | 24.46 | -11.59 |
Change in Accounts Payable | -8.02 | -8.02 | -27.15 | 17.5 | -16 | 10.35 |
Change in Other Net Operating Assets | - | - | - | -0.01 | - | - |
Operating Cash Flow | -99.93 | 15.84 | -0.88 | 90.26 | 102.41 | 157.34 |
Operating Cash Flow Growth | - | - | - | -11.87% | -34.91% | 43.82% |
Capital Expenditures | -0.69 | -1.05 | -1.13 | -1.63 | -1.38 | -2.61 |
Sale of Property, Plant & Equipment | 0.16 | 0.09 | - | - | - | 0.04 |
Cash Acquisitions | -8.05 | -8.05 | - | 0.1 | - | - |
Investment in Securities | 140.85 | 80.43 | 79.87 | -175.99 | -639.59 | -144.96 |
Other Investing Activities | 21.47 | 11.75 | 15.63 | 30.18 | 13.45 | 6.38 |
Investing Cash Flow | 153.86 | 83.18 | 94.37 | -147.34 | -627.53 | -141.15 |
Long-Term Debt Repaid | - | -4.55 | -5.64 | -4.89 | -4.23 | - |
Net Debt Issued (Repaid) | -6.42 | -4.55 | -5.64 | -4.89 | -4.23 | - |
Issuance of Common Stock | 2.21 | 0.89 | 0.58 | - | 680.37 | - |
Repurchase of Common Stock | -10.18 | -10.18 | -29.85 | - | - | - |
Common Dividends Paid | -29.55 | -32.47 | -34.68 | -31.4 | -40.95 | -20.07 |
Dividends Paid | -29.55 | -32.47 | -34.68 | -31.4 | -40.95 | -20.07 |
Other Financing Activities | 11.56 | - | - | - | -13.76 | - |
Financing Cash Flow | -32.38 | -46.31 | -69.59 | -36.29 | 621.44 | -20.07 |
Foreign Exchange Rate Adjustments | 0.02 | 0.03 | 0.03 | 0.14 | -0.04 | -0.11 |
Net Cash Flow | 21.57 | 52.74 | 23.93 | -93.22 | 96.28 | -3.99 |
Free Cash Flow | -100.62 | 14.79 | -2.01 | 88.63 | 101.03 | 154.73 |
Free Cash Flow Growth | - | - | - | -12.27% | -34.70% | 43.96% |
Free Cash Flow Margin | -43.69% | 7.07% | -0.77% | 22.43% | 24.03% | 25.20% |
Free Cash Flow Per Share | -0.51 | 0.07 | -0.01 | 0.43 | 0.49 | 1.01 |
Cash Income Tax Paid | 10.25 | 21.13 | 23.28 | 23.72 | 30.79 | 37.13 |
Levered Free Cash Flow | 343.41 | -16.98 | -52.42 | 49.6 | 87.57 | 105.67 |
Unlevered Free Cash Flow | 343.55 | -16.84 | -52.28 | 49.76 | 87.7 | 105.67 |
Change in Working Capital | -2.29 | -2.29 | -46.97 | -1.23 | 5.7 | 9.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.